Braavos Capital
Investor profile
Venture capital
Also recorded as: Braavos Investment Advisers
Deals
8
distinct rounds
Companies
8
backed
Active span
2021–2025
5 yrs
Total round €
€318M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- Oxford Science Enterprises4
- Lansdowne Partners2
- 2xN1
- Addition1
- Applied Ventures1
- Aramco Ventures1
- Axial1
- Cambridge Innovation Capital1
- Chevron Technology Ventures1
- Clean Energy Ventures1
- Doral Energy-Tech Ventures1
- Eni Next1
- F-Prime Capital1
- General Catalyst1
- Hermann Hauser1
- Hostplus1
- ICM HPQC Fund1
- IP Group1
- Jalal Bagherli1
- Khosla Ventures1
- Kiko Ventures (IP Group)1
- Legal & General1
- LLC1
- M&G Investments1
- OrbiMed1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Osler Diagnostics | UK | 1 | €85M |
| Charm Therapeutics | UK | 1 | €48M |
| First Light Fusion | UK | 1 | €40M |
| PQShield | UK | 1 | €35M |
| Oxford Ionics | UK | 1 | €34M |
| Salience Labs | UK | 1 | €29M |
| SpyBiotech | UK | 1 | €27M |
| Oxccu | UK | 1 | €21M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Osler Diagnostics | Series C | €85M | 2022-11 |
| Charm Therapeutics | Series A | €48M | 2022-06 |
| First Light Fusion | Series C | €40M | 2022-02 |
| PQShield | Series B | €35M | 2024-06 |
| Oxford Ionics | Series A | €34M | 2023-01 |
| Salience Labs | Series A | €29M | 2025-02 |
| SpyBiotech | Series A | €27M | 2021-02 |
| Oxccu | Series A | €21M | 2023-06 |